The underlying mechanisms of masked diabetes insipidus are accounted by various effects of glucocorticoid, such as inhibition of vasopressin release [14], reduced water absorption at the proximal tubule [15], and stimulation of atrial natriuretic peptide secretion to enhance the diuretic effect [16]. The gene discussed is NPPA; the disease is Central diabetes insipidus.